“…Furthermore, cell and tissue ACE levels have also been shown to be modulated by ACE gene polymorphism in humans. 11,12 Since Cambien et al 13 first described a significant association between the I/D polymorphism and myocardial infarction, many studies have tried to examine the association of the ACE genotype, not only with ischemic heart disease 14 -17 but with a variety of conditions ranging from hypertension 18,19 to coronary artery restenosis, 14,20,21 cardiac hypertrophy, 16,22,23 pulmonary hypertension, 24 diabetes, 25 and nephropathy. 26 -28 The results of these studies are contradictory and stress the importance of experimental models for testing the impact of the ACE gene polymorphism and its associated modulation of ACE expression on the cardiovascular and renal responses to these pathological processes.…”